10-Q Filing

RELMADA THERAPEUTICS, INC. CIK: 1553643 Q1 2019

Filing Information

Form Type	10-Q
Accession Number	`0001213900-18-015476`
Period End Date	20180930
Filing Date	20181113
Fiscal Year	2019
Fiscal Period	Q1
XBRL Instance	rlmd-20180930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 68 Income Statement 22 Cash Flow Statement 58

Balance Sheet 68 line items

Line Item	Tag	Value	Unit	Period
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	$4.01M	USD	Point-in-time
Promissory notes payable, net of discount	`DebtInstrumentUnamortizedDiscountNoncurrent`	$4.55M	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$4.68M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	200.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$887.49K	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	-	USD	Point-in-time
Other receivable	`OtherReceivablesNetCurrent`	$7.62K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Lease payments receivable - short-term	`LeaseIncentiveReceivableCurrent`	$64.49K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Lease payments receivable - short-term	`LeaseIncentiveReceivableCurrent`	$65.85K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$426.92K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$316.82K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$2.74M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.27M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$12.08K	USD	Point-in-time
Fixed assets, net of accumulated depreciation	`PropertyPlantAndEquipmentNet`	$10.68K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.55M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	12.55M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.55M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	12.55M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$24.79K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$18.91K	USD	Point-in-time
Lease payments receivable - long-term	`LeaseIncentiveReceivableNoncurrent`	$256.26K	USD	Point-in-time
Lease payments receivable - long-term	`LeaseIncentiveReceivableNoncurrent`	$273.24K	USD	Point-in-time
Total assets	`Assets`	$1.56M	USD	Point-in-time
Total assets	`Assets`	$3.05M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$765.44K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.02M	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$966.16K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$659.46K	USD	Point-in-time
Units to be issued	`UnitsToBeIssuedCurrent`	-	USD	Point-in-time
Units to be issued	`UnitsToBeIssuedCurrent`	$404.50K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$200.20K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$285.17K	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$4.19M	USD	Point-in-time
Derivative liabilities	`DerivativeLiabilitiesCurrent`	$4.51M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$5.90M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$7.10M	USD	Point-in-time
Promissory notes payable, net of discount of $4,012,023 and $4,548,543	`LongTermNotesPayable`	$2.66M	USD	Point-in-time
Promissory notes payable, net of discount of $4,012,023 and $4,548,543	`LongTermNotesPayable`	$3.19M	USD	Point-in-time
Total liabilities	`Liabilities`	$8.56M	USD	Point-in-time
Total liabilities	`Liabilities`	$10.30M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 12,549,870 and 12,549,870 shares issued and outstanding, respectively	`CommonStockValue`	$12.55K	USD	Point-in-time
Common stock, $0.001 par value,100,000,000 shares authorized, 12,549,870 and 12,549,870 shares issued and outstanding, respectively	`CommonStockValue`	$12.55K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$88.97M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$88.82M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-94.34M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-97.72M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-5.51M	USD	Point-in-time
Total stockholders' equity (deficit)	`StockholdersEquity`	$-8.74M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$1.56M	USD	Point-in-time
Total liabilities and stockholders' equity (deficit)	`LiabilitiesAndStockholdersEquity`	$3.05M	USD	Point-in-time

Income Statement 22 line items

Line Item	Tag	Value	Unit	Period
Research and development	`ResearchAndDevelopmentExpense`	$1.42M	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$165.75K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$989.75K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$815.11K	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$2.41M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$980.86K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-980.86K	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-2.41M	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-5.70K	USD	1 Quarter
Change in fair value of derivative liabilities	`DerivativeGainLossOnDerivativeNet`	$-318.54K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$2.52K	USD	1 Quarter
Interest income (expense), net	`InterestIncomeExpenseNet`	$-650.32K	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	-	USD	1 Quarter
Other income	`OtherNonoperatingIncome`	$2.35K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-968.86K	USD	1 Quarter
Total other income (expenses)	`NonoperatingIncomeExpense`	$-830.00	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-981.69K	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.27	USD	1 Quarter
Net loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.55M	shares	1 Quarter
Weighted average number of common shares outstanding - basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	12.53M	shares	1 Quarter

Cash Flow Statement 58 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-3.38M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-981.69K	USD	1 Quarter
Depreciation expense	`Depreciation`	$548.00	USD	1 Quarter
Depreciation expense	`Depreciation`	$1.41K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$152.80K	USD	1 Quarter
Stock-based compensation	`ShareBasedCompensation`	$68.87K	USD	1 Quarter
Amortization of deferred financing costs	`AmortizationOfDebtDiscountPremium`	$2.82K	USD	1 Quarter
Amortization of deferred financing costs	`AmortizationOfDebtDiscountPremium`	$536.52K	USD	1 Quarter
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$5.70K	USD	1 Quarter
Change in fair value of derivative liabilities	`IncreaseDecreaseInDerivativeLiabilities`	$318.54K	USD	1 Quarter
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-81.98K	USD	1 Quarter
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-7.62K	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasePaymentReceivable`	$-14.37K	USD	1 Quarter
Lease payment receivable	`IncreaseDecreaseInLeasePaymentReceivable`	$-15.62K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-103.11K	USD	1 Quarter
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-115.98K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-232.51K	USD	1 Quarter
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$253.92K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$306.71K	USD	1 Quarter
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$-42.25K	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.67M	USD	1 Quarter
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-979.05K	USD	1 Quarter
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	$2.59K	USD	1 Quarter
Purchase of fixed assets	`PaymentsToAcquireProductiveAssets`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	1 Quarter
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.59K	USD	1 Quarter
Proceeds from promissory notes and warrants, net of fees	`ProceedsFromNotesPayable`	-	USD	1 Quarter
Proceeds from promissory notes and warrants, net of fees	`ProceedsFromNotesPayable`	$4.04M	USD	1 Quarter
Principal payments of notes payable	`RepaymentsOfNotesPayable`	$82.51K	USD	1 Quarter
Principal payments of notes payable	`RepaymentsOfNotesPayable`	$84.97K	USD	1 Quarter
Units funds received	`UnitFundsReceived`	-	USD	1 Quarter
Units funds received	`UnitFundsReceived`	$404.50K	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.96M	USD	1 Quarter
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$319.53K	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$2.97M	USD	1 Quarter
Net (decrease) increase in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.35M	USD	1 Quarter
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.68M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at beginning of the period	`CashAndCashEquivalentsAtCarryingValue`	$887.49K	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$4.68M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$2.24M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$1.71M	USD	Point-in-time
Cash and cash equivalents at end of the period	`CashAndCashEquivalentsAtCarryingValue`	$887.49K	USD	Point-in-time
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Income taxes	`IncomeTaxesPaid`	-	USD	1 Quarter
Interest	`InterestPaidNet`	$1.51K	USD	1 Quarter
Interest	`InterestPaidNet`	$1.97K	USD	1 Quarter
Issuances of common stock resulting from cashless exercise of warrants	`IssuancesOfCommonStockResultingFromCashlessExerciseOfWarrants`	$17.00	USD	1 Quarter
Issuances of common stock resulting from cashless exercise of warrants	`IssuancesOfCommonStockResultingFromCashlessExerciseOfWarrants`	-	USD	1 Quarter
Warrants issued to placement agent	`WarrantsIssuedToPlacementAgent`	$75.58K	USD	1 Quarter
Warrants issued to placement agent	`WarrantsIssuedToPlacementAgent`	-	USD	1 Quarter
Warrants issued to promissory note holders	`WarrantsIssuedToPromissoryNoteHolders`	$841.62K	USD	1 Quarter
Warrants issued to promissory note holders	`WarrantsIssuedToPromissoryNoteHolders`	-	USD	1 Quarter
Derivative associated with issuance of promissory notes	`DerivativeAssociatedWithIssuanceOfPromissoryNotes`	$2.34M	USD	1 Quarter
Derivative associated with issuance of promissory notes	`DerivativeAssociatedWithIssuanceOfPromissoryNotes`	-	USD	1 Quarter
Debt issuance cost from accrued financing fees	`DebtIssuanceCostFromAccruedFinancingFees`	$108.49K	USD	1 Quarter
Debt issuance cost from accrued financing fees	`DebtIssuanceCostFromAccruedFinancingFees`	-	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.